According to the Centers for Disease Control and Prevention (CDC), more than 795,000 people have a stroke each year in the United States. Every 4 minutes, an individual dies from a stroke. The financial impact of strokes on the healthcare system is staggering, with an estimated $34 billion spent annually in the US, which includes the cost of healthcare services, medicines to treat stroke patients, and lost productivity. Although hemorrhagic strokes comprise only 13% of all strokes, they are part...

For the emergency physician, hospitalist, and critical care physician, upper GI or lower GI Bleeding can represent a life-threatening emergency in the anticoagulated patient presenting to the emergency department or intensive care unit,  In this CME-based educational program, the clinician is provided with multiple cases of patients with life-threatening GI bleedingThe development of direct oral anticoagulants (DOACs), such as dabigatran, betrixaban, rivaroxaban, apixaban, and edoxaban, rep...

According to the Centers for Disease Control and Prevention (CDC), more than 795,000 people have a stroke each year in the United States. Every 4 minutes, an individual dies from a stroke. The financial impact of strokes on the healthcare system is staggering, with an estimated $34 billion spent annually in the US, which includes the cost of healthcare services, medicines to treat stroke patients, and lost productivity. Although hemorrhagic strokes comprise only 13% of all strokes, they are part...

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Over...

The impact of the ever-changing COVID-19 pandemic is creating a rapidly evolving clinical environment for healthcare providers (HCPs). As a result, HCPs are challenged to keep up with the most current clinical information, while constantly evolving their approaches to the management of anticoagulated patients with severe bleeding. As a result, innovative approaches are required to educate these HCPs on how they can make a positive impact on patient care and improve clinical outcomes in the new C...

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Ove...

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Ove...

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Ove...

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Ove...

As the utilization of direct oral anticoagulants (DOACs) increases, there is a parallel increase in major bleeding events, especially intracranial hemorrhages, requiring hospitalization. Clinicians are not recognizing or distinguishing major from minor bleeding, or appropriately employing emergent options to manage major bleeding. Recent solutions for DOAC related life-threatening bleeding are under-recognized and under-utilized solutions for patients with these life-threatening emergencies. Ove...